Although both neutrophil- and eosinophil-platelet aggregates of metabolic syndrome patients showed increased CX3CR1 expression when compared with the control group (Figure 6C,D, Heparin), neither expressed CX3CR1 after platelet dissociation (Figure 6C,D, EDTA). The gene discussed is CX3CR1; the disease is metabolic syndrome.